SpyBiotech is a UK-based company with a novel vaccine platform to target infectious diseases, cancer and chronic diseases.
SpyBiotech was spun out of the University of Oxford in 2017. Its proprietary protein superglue technology binds antigens to vaccine delivery platforms in a way which minimizes delivery risk and enhances immunogenicity and efficacy.
The company’s current lead candidate is against human cytomegalovirus (HCMV), with clinical studies planned for this year.
Company Details
- Employees
- 25
- Founded
- -
- Address
- 7600 Quorum,
- Phone
- 4401865582088
- co****@****ech.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- spybiotech.com
- Keywords
- Vaccine Development.
- HQ
- Oxford
Spybiotech Questions
Spybiotech's helpline number is 4401865582088
Spybiotech's website is spybiotech.com
Spybiotech's LinkedIn profile is https://www.linkedin.com/company/spybiotech
Spybiotech has
25 employees.
View email and phone details for 25
employees at Spybiotech.
Spybiotech's industry is
Biotechnology Research
Spybiotech's top competitors are
Refeyn,
Oni,
Oxford Nanopore Technologies,
Evox Therapeutics Ltd,
Orbit Discovery,
Oxford Biodynamics Plc,
Omass Therapeutics,
Nucleome Therapeutics,
Neovac,
Immunocore.
Spybiotech's support email address is contact@spybiotech.com
Spybiotech's categories are Biotechnology Research
Spybiotech's founding year is 2017
